Genomics

Dataset Information

Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon responses via MYC/CDK2/DNMT1 pathway.


ABSTRACT: Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon responses via MYC/CDK2/DNMT1 pathway.

PROVIDER: PRJNA1204289 | ENA |

REPOSITORIES: ENA